Cytochrome P450, the oxygen-activating enzyme in xenobiotic metabolismSNYDER, Robert.Toxicological sciences (Print). 2000, Vol 58, Num 1, pp 3-4, issn 1096-6080Article

N-oxygenation of clozapine by flavin-containing monooxygenaseTUGNAIT, M; HAWES, E. M; MCKAY, G et al.Drug metabolism and disposition. 1997, Vol 25, Num 4, pp 524-527, issn 0090-9556Article

Bacteria and the biodegradation of chemicals achieved naturally, by combination, or by constructionGOTTSCHALK, G; KNACKMUSS, H.-J.Angewandte Chemie. International edition in English. 1993, Vol 32, Num 10, pp 1398-1408, issn 0570-0833Article

Size limits of thiocarbamides accepted as substrates by human flavin-containing monooxygenase 1YOUNG MI KIM; ZIEGLER, D. M.Drug metabolism and disposition. 2000, Vol 28, Num 8, pp 1003-1006, issn 0090-9556Article

Cytochromes P450 enzymes for clean food-processing : limitations of imitations!WISEMAN, A; LEWIS, D. F; RIDGWAY, T et al.Journal of chemical technology and biotechnology (1986). 2000, Vol 75, Num 1, pp 3-5, issn 0268-2575Article

Biocatalytic conversion of avermectin to 4-oxo-avermectin : Characterization of biocatalytically active bacterial strains and of cytochrome P450 monooxygenase enzymes and their genesJUNGMANN, Volker; MOLNAR, Istvan; HAMMER, Philip E et al.Applied and environmental microbiology (Print). 2005, Vol 71, Num 11, pp 6968-6976, issn 0099-2240, 9 p.Article

A novel P450 expressed at the high level in rat brainKOMORI, M.Biochemical and biophysical research communications (Print). 1993, Vol 196, Num 2, pp 721-728, issn 0006-291XArticle

Identification of novel variants of the flavin-containing monooxygenase gene family in African AmericansFURNES, Bjarte; JINONG FENG; SOMMER, Steve S et al.Drug metabolism and disposition. 2003, Vol 31, Num 2, pp 187-193, issn 0090-9556, 7 p.Article

Human cytochrome P450 enzymes : A status report summarizing their reactions, substrates, inducers, and inhibitorsRENDIC, S; DI CARLO, F. J.Drug metabolism reviews (Softcover ed.). 1997, Vol 29, Num 1-2, pp 413-580, issn 0360-2532Conference Paper

Cerebral metabolism of imipramine and a purified flavin-containing monooxygenase from human brainBHAGWAT, S. V; BHAMRE, S; BOYD, M. R et al.Neuropsychopharmacology (New York, NY). 1996, Vol 15, Num 2, pp 133-142, issn 0893-133XArticle

Developmental regulation of flavin-containing monoxygenase (FMO) isoforms 1 and 2 in pregnant rabbitMIN-YOUNG LEE; SMILEY, S; KADKHODAYAN, S et al.Chemico-biological interactions. 1995, Vol 96, Num 1, pp 75-85, issn 0009-2797Article

FAD-dependent enzymes involved in the metabolic oxidation of xenobiotics = Enzymes FAD-dépendantes impliquées dans l'oxydation métabolique des xénobiotiquesSTROLIN BENEDETTI, M.Annales pharmaceutiques françaises. 2011, Vol 69, Num 1, pp 45-52, issn 0003-4509, 8 p.Conference Paper

New insights into the first oxidative phenol coupling reaction during vancomycin biosynthesisGEIB, Nina; WOITHE, Katharina; ZERBE, Katja et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 10, pp 3081-3084, issn 0960-894X, 4 p.Article

CYP2C9 inhibition : Impact of probe selection and pharmacogenetics on in vitro inhibition profilesKUMAR, Vikas; WAHLSTROM, Jan L; ROCK, Dan A et al.Drug metabolism and disposition. 2006, Vol 34, Num 12, pp 1966-1975, issn 0090-9556, 10 p.Article

Structure-activity relationship and elucidation of the determinant factor(s) responsible for the mechanism-based inactivation of cytochrome P450 2B6 by substituted phenyl diaziridinesKOBAYASHI, Yoshimasa; SRIDAR, Chitra; KENT, Ute M et al.Drug metabolism and disposition. 2006, Vol 34, Num 12, pp 2102-2110, issn 0090-9556, 9 p.Article

Biocatalytic conversion of avermectin to 4-oxo-avermectin : Heterologous expression of the ema1 cytochrome P450 monooxygenaseMOLNAR, Istvan; HILL, D. Steven; ZIRKLE, Ross et al.Applied and environmental microbiology (Print). 2005, Vol 71, Num 11, pp 6977-6985, issn 0099-2240, 9 p.Article

CpG methylation of the mouse CYP1A2 promoterJIN, Bowhan; DUK WOONG PARK; NAM, Ki-Whan et al.Toxicology letters. 2004, Vol 152, Num 1, pp 11-18, issn 0378-4274, 8 p.Article

Validation of model of cytochrome P450 2D6: An in silico tool for predicting metabolism and inhibitionKEMP, Carol A; FLANAGAN, Jack U; VAN ELDIK, Annamaria J et al.Journal of medicinal chemistry (Print). 2004, Vol 47, Num 22, pp 5340-5346, issn 0022-2623, 7 p.Article

Imidacloprid insecticide metabolism: human cytochrome P450 isozymes differ in selectivity for imidazolidine oxidation versus nitroimine reductionSCHULZ-JANDER, Daniel A; CASIDA, John E.Toxicology letters. 2002, Vol 132, Num 1, pp 65-70, issn 0378-4274Article

In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO) : metabolism of benzydamine and caffeine by FMO and P450 isoformsLANG, Dieter H; RETTIE, Allan E.British journal of clinical pharmacology. 2000, Vol 50, Num 4, pp 311-314, issn 0306-5251Article

Neutrophil- and glutathione-mediated hepatotoxicity of α-naphthylisothiocyanateROTH, R. A; DAHM, L. J.Drug metabolism reviews (Softcover ed.). 1997, Vol 29, Num 1-2, pp 153-165, issn 0360-2532Conference Paper

Cytochrome P-450 and drug development for skin diseasesAHMAD, N; AGARWAL, R; MUKHTAR, H et al.Skin pharmacology. 1996, Vol 9, Num 4, pp 231-241, issn 1011-0283Article

The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 geneKIYOHARA, C; HIROHATA, T; INUTSUKA, S et al.Japanese journal of cancer research. 1996, Vol 87, Num 1, pp 18-24, issn 0910-5050Article

Structural characteristics of flavin-containing monooxygenase genes one and two (FMO1 and FMO2)WYATT, M. K; PHILPOT, R. M; CARVER, G et al.Drug metabolism and disposition. 1996, Vol 24, Num 12, pp 1320-1327, issn 0090-9556Article

Influence of environmental factors on the physiological condition and hepatic ethoxyresorufin O-deethylase (EROD) activity of gizzard shad (Dorosoma cepedianum)LEVINE, S. L; ORIS, J. T; WISSING, T. E et al.Environmental toxicology and chemistry. 1995, Vol 14, Num 1, pp 123-128, issn 0730-7268Article